Alessio, L., Berlin, A., Dell’Orto, A., Toffoletto, F., Ghezzi, I. (1985). Reliability of urinary creatinine as a parameter used to adjust values of urinary biological indicators. Int. Arch. Occup. Environ. Health, 55, 99-106.
Banks Anderson, Y., Birnbaum, L.S. (1993). Dermal absorption of TCDD : Effect of age. In Health Risk Assessment. Dermal and Inhalation Exposure and Absorption of Toxicants., eds R.G.M. Wang, J.B. Knaak, H.I. Maibach, 127-134. Florida, CRC Press.
Bender, A.D. (1965). The effect of increasing age on the distribution of peripheral blood flow in man. J. Am. Geriatr. Soc., 13, 192-198.
Beierschmitt, W.P., Weiner, M. (1986). Age-related changes in renal metabolism of acetaminophen in male Fischer 344 rats. Age, 9, 7-13.
Bennett, W.D., Zeman, K.L., Kim, C. (1996). Variability of fine particle deposition in healthy adults : Effect of age and gender. Am. J. Respir. Crit. Care Med., 153, 1641-1647.
Billiet, L., Baisier, W., Naedts, J.P. (1963). Effet de la taille, du sexe et de l’âge sur la capacité de diffusion pulmonaire de l’adulte normal. J. Physiol., 55, 199-200.
Birnbaum, L.S. (1983). Distribution and excretion of 2,3,6,2’,3’,6’- and 2,4,5,2’,4’,5’-hexachlorobiphenyl in senescent rats. Toxicol. Appl. Pharmacol., 70, 262-272.
Boeniger, M.F., Lowry, L.K., Rosenberg, J. (1993). Interpretation of urine results used to assess chemical exposure with emphasis on creatinine adjustments : a review. Am. Ind. Hyg. Assoc. J., 54, 615-627.
Branchet, M.C., Boisnic, S., Rober,t A.M. (1990). Skin Thickness changes in normal aging skin. Gerontology, 36, 28-35.
Brodie, M.J., Boobis, A.R., Bulpitt, C.J., Davies, D.S. (1981). Influence of liver disease and environmental factors on hepatic mono-oxygenase activity in vitro. Eur. J. Clin. Pharmacol., 20, 39-46.
Castleden C.M., George, C.F., Marcer, D., Hallet, C. (1977). Increased sensitivity to nitrazepam in old age. Br. Med. J., 1, 10-12.
Christophers, E., Kligman, A.M. (1965). Percutaneous absorption in aged skin. In Advances in the Biology of the Skin, ed W. Montagna, p. 163. Pergammon Press, Oxford.
Cooper, R.L., Goldman, J.M., Rehnberg, G.L. (1986). Pituitary function following treatment with reproductive toxins. Environ. Health Perspect., 70, 177-184.
Crapo, R.O., Morris, A.H. (1981). Standardized single breath normal values for carbon monoxide diffusing capacity. Am. Rev. Respir. Dis., 123, 185.
Dhar, S., Shastri, S.R., Lenora, R.A.K. (1976). Aging and the respiratory system. Med. Clin. North Am., 60, 1121-39.
Donevan, R.E., Palmer, W.H., Varvis, C.J., Bates, D.V. (1959). Influence of age on pulmonary diffusing capacity. J. Appl. Physiol., 14, 483-492.
Dybing, E., Soderlung, E.J. (1999). Situations with enhanced chemical risk due to toxicokinetic and toxicodynamic factors. Reg. Toxicol. Pharmacol., 30, S27-S30.
Elder, A.C.P., Gelein, R., Finkelstein, J.N., Cox, C., Oberdörster, G. (2000). Pulmonary Inflammatory Response to Inhaled Ultrafine Particles is Modified by Age, Ozone Exposure, and Bacterial Toxin. Inhalation Toxicology, 12(Supplement 4), 227-246.
Evers, B.M., Townsend, C.M.J., Thompson, J.C. (1994). Organ physiology of aging. Surg. Clin. North Am., 74, 23-39.
Fenske, N.A., Lober, C.W. (1986). Structural and functional changes in normal aging skin. J. Am. Acad. Dermatol., 15, 571-585.
George, J., Byth, K., Farrell, G.C. (1995). Age but not gender selectively affects expression of individual cytochrome P450 proteins in human liver. Biochem. Pharmacol., 50, 5, 727-730.
Gilchrest, B.A. (1984). Skin and aging processes. CRC Press, Boca Raton, Florida.
Gleason, M.S. (1996). Pharmacology issues in aging. Crit. Care Nurs., 19, 2, 7-12.
Grandison, M.K., Boudinot, F.D. (2000). Age-related changes in protein binding of drugs. Implications for therapy. Clin. Pharmacokinet., 38, 3, 271-290.
Greenblatt, D.J., Sellers, E., Shader, M.D. (1982). Drug disposition in old age. New Engl. J. Med., 306, 18, 1081-1088.
Gurwitz, J.H., Avorn, J. (1991). The ambiguous relation between aging and adverse drug reactions. Ann. Int. Med., 114, 956-966.
Hall, D.A., Blackett, A.D., Zajac, A.R., Switala, S., Airey, C.M. (1981). Changes in skinfold thickness with increasing age. Age Ageing, 10, 19-23.
Hastie, I.R., Millard, P.H. (1983). The quantification of skin transparency. Br. J. Dermatol., 108, 315-320.
Hunt, C.M., Westerkam, W.R., Stave, G. (1992). Effect of age and gender on the activity of human hepatic CYP3A. Biochem. Pharmacol., 44, 2, 275-283.
Jori, A., Disalle, E., Quadri, A. (1972). Rate of aminopyrine diappearance in young and aged humans. Pharmacol., 8, 273-279.
Kitani, K. (1988). Drugs and the aging liver. Life Chem. Rep., 6, 143-230.
Kitani, K. (1990). Aging and the liver. Progress in Liver Diseases., 9, 603-623.
Kligman, A.M. (1979). Perspectives and problems in cutaneous gerontology. J. Invest. Dermatol., 73, 39-46.
Kyle, M.E., Kocsis, J.J. (1985). The effect of age on salicylate-induced nephrotoxicity in male rats. Toxicol. Appl. Pharmacol., 81, 337-347.
Lamy, P.P. (1991). Physiological changes due to age.Pharmacodynamic changes of drug action and implications for therapy. Drugs & Aging, 1, 5, 385-404.
Laville, A. et coll. (1998). Les travailleurs âgés. Encyclopédie de sécurité et de santé au travail, 4e édition. Bureau international du travail.
Lavker, R.M. (1979). Structural alterations in exposed and unexposed aged skin. J. Invest. Dermatol., 73, 59-66.
Lavker, R.M., Zheng, P., Dong, G. (1987). Aged skin : a study by light, transmission electron, and scanning electron microscopy. J. Invest. Dermatol., 88 44s-51s.
Le Couteur, D.G., McLean, A.J. (1998). The aging liver. Drug clearance and an oxygen diffusion barrier hypothesis. Clin. Pharmacol., 34, 5, 359-373.
Leveque J.L., Corcuff P., Rigal J., Agache O. (1984). In vivo studies of the evolution of physical properties of the human skin with age. Int. J. Dermatol. 23, 322.
Lichtman, S.M. (1995). Physiological aspects of aging. Implications for the treatment of cancer. Drugs & Aging, 7, 3, 212-225.
Lin, Y-S., Smith, T.J., Kelsey, K.Y., Wypij, D. (2001). Human physiologic factors in respiratory uptake of 1,3-butadiene. Environ. Hlth, Perspect., 109, 9, 921-926.
Linderman, R.D. (1990). Overview : Renal physiology and pathophysiology and aging. Am. J. Kidney Dis., 26, 4, 275-282.
Mauderly, J.L. (2000). Animal Models for the Effect of Age on Susceptibility to Inhaled Particulate Matter. Inhalation Toxicology., 12, 863-900.
Meier, D.E. (1984). The cell biology of aging. In Geriatric Medicine, eds C.K. Cassel, J.R. Walsh, J.R., p. 3-13, New York, Springer-Verlag.
Meyer, B.R. (1989). Renal function in aging. J. Am. Geriatrics Soc., 37, 791-800.
Miura, K., Goldstein, R.S., Morgan, D.G., Pasino, D.A., Hewitt, W.R., Hook, J.B. (1987). Age-related differences in susceptibility to renal ischemia in rats. Toxicol. Appl. Pharmacol., 87, 284-296.
Montagna, W., Carlisle, K. (1979). Structural changes in aging human skin. J. Invest. Dermatol., 73, 47-53.
Morris, J.F. (1994). Physiological changes due to age. Implications for respiratory drug therapy. Drugs & Aging., 4, 3 207-220.
Rabovsky, J., Marion, K.J., Groseclose, R.D., Lewis, T.R., Peterson, M. (1984). Low dose chronic inhalation of diesel exhaust and/or coal dust by rats : effect of age and exposure on lung and liver cytochrome P450. Xenob., 14, 595-598.
Rehnberg, G.L., Linder, R., Goldman, J.M., Hein, J.F., McElroy, W.K., Cooper, R.L. (1988). Changes in testicular and serum hormone concentrations in the male rat following treatment with m-dinitrobenzene. Toxicol. Appl. Pharmacol., 95, 255-264.
Reidenberg, M.M. (1980). Drugs in the elderly. Bull. NY Acad. Med., 56, 703-714.
Robertson, I.G.C., Birnbaum, L.S. (1982). Age-related changes in mutagen activation by rat tissues. Chem. Biol. Interact., 38, 243-252.
Rogers, J., Bloom, F.E. (1985). Neurotransmitter metabolism and function in the aging central nervous system. In Handbook of the biology of aging, 2e ed., eds C.E. Finch., E.L. Schneider, p. 645-692, New York, Van Nostrand Reinhold Co.
Rougier, A., Lotte, C., Corcuff, P., Maibach, H.I. (1988). Relationship between skin permeability and corneocyte size according to anatomic site, age, and sex in man. J. Soc. Cosmet. Chem., 39, 15.
Roskos, K.V., Guy, R.H., Maibach, H.I. (1986). Percutaneous absorption in the aged. Dermatol. Clin., 4, 455.
Roskos, K.V., Maibach, H.I., Guy, R.H. (1989). The effect of aging on percutaneous absorption in man. J. Pharmacokinet. Biopharm., 17, 617.
Roth, G.S. (1979). Hormone action during aging : alterations and mechanisms. Mech. Ageing Dev., 9, 497-514.
Schmucker, D.L. (1979). Aging and drug disposition : an update. Pharmacol. Rev., 30, 133-148.
Schuurman, H.J., Krajnc-Franken, M.A.M., Kuper, C.F., Van Loveren, H., Vos, J.G. (1990). Immune system. In Fundamentals of toxicologic pathology. Eds W.M. Haschek-Hoch, C.G. Rousseaux, p. 1-103, New York, London, San Francisco, Academic Press.
Sellers, E.M. (1989). Geriatric clinical pharmacology. In Principles of Medical Pharmacology, 5th ed., eds H. Kalant, W.H.E. Roschlau, p. 697-706, Toronto, Decker Inc.
Shuster, S., Black, M.M., McVitie, E. (1975). The influence of age and sex on skin thickness, skin collagen and density. Br. J. Dermatol., 93, 639-643.
Statistique Canada (1996a). Recensement 1996, compilations spéciales. Ottawa.
Statistique Canada (1996b). Travailleurs âgés et santé. No 75-001-XPF, Ottawa.
Sun, J., Strobel, H.W. (1986). Aging affects the drug metabolism systems of rat liver, kidney, colon, and lung in a differential fashion. Exp. Gerontol., 21, 523‑534.
Swift, C.G., Homeida, M., Halliwell, M., Roberts, C.J.C. (1978). Antipyrine disposition and liver size in the elderly. Eur J. Clin. Pharmacol., 14, 149-152.
Tagami, H. (1971). Functional characteristics of aged skin. Acta Dermatol., 19, 66-67.
Tan, C.Y., Marks, R., Payne, P. (1981). Comparison of xeroradiographic and ultrasound detection of corticosteroid induced dermal thinning. J. Invest. Dermatol. 76, 126-128.
Tockman, M.S. (1990). Aging of the respiratory system. In Geriatric Surgery, ed M.R. Katlic, p. 75-84, Baltimore, Urban & Schwartzberg.
Troncale, J.A. (1996). The aging process. Physiologic changes and pharmacologic implications. Postgraduate Medicine-Aging and Drugs, 99, 5, 111-122.
US EPA (United States Environmental Protection Agency). (1999). Air quality criteria for particulate matter, 1-111, EPA/600/P-99/002a, Washington, DC, US EPA.
Vestal, R.E. (1989). Aging and determinants of hepatic drug clearance. Hepatology, 9, 331-334.
Vestal, R.E. (1997). Aging and pharmacology. Cancer, 80, 7, 1302-1310.
Wahba, W.M. (1983). The influence of aging on lung function-clinical significance of changes from age twenty. Anesth. Analg., 62, 764-76.
Woodhouse, K.W., Mutch, E., Rawlins, M.D., James, O.F.W. (1984). The effect of age on pathways of drug metabolism in human liver. Age and Ageing, 13, 328-334.
Yang, R.S.H., Tallant, M.J., McKelvey, J.A. (1984). Age-dependent pharmacokinetics changes of ethylenediamine in Fischer 344 rats parallel to a two-year chronic toxicity study. Fundam. Appl. Toxicol., 4, 663-670.
Yang, M.C., McLean, A.J., Le Couteur, D.G. (2002). Age-related alteration in hepatic disposition of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and pesticides. Pharmacol. Toxicol., 90, 203-207.
Yates, M.S., Hiley, C.R. (1979). The effect of age and cardiac output and its distribution in the rat. Experientia, 35, 78-79.
York, J.L. (1982). Body water content, ethanol pharmacokinetics and the responsiveness to ethanol in young and old rats. Dev. Pharmacol. Ther., 4, 106-116.
Yuen, G.J. (1990). Altered pharmacokinetics in the elderly. Clin. in Geriatr. Med., 6, 2, 257-267.